Physician profile
Benjamin E Jacobs
NPI 1578790341
$15,870.00
in general payments reported to CMS, 2019-2025
61 companies · $3,189 in 2025
The $3,189 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,968 · 2020: $6,006 · 2021: $238 · 2022: $1,500 · 2023: $139 · 2024: $1,830 · 2025: $3,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,158.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,826.45 | 2019-2025 | Enhertu, Tagrisso, Calquence |
| G1 Therapeutics, INC. | $1,500.00 | 2022 | |
| Blueprint Medicines Corporation | $1,498.12 | 2020 | |
| Seagen INC. | $1,311.64 | 2019-2020 | |
| Rigel Pharmaceuticals, INC. | $1,018.83 | 2019-2020 | |
| Janssen Biotech, INC. | $586.62 | 2019-2025 | Erleada, Talvey, Tecvayli |
| Novartis Pharmaceuticals Corporation | $578.53 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $477.82 | 2019-2025 | Opdualag, Opdivo |
| Incyte Corporation | $394.70 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Daiichi Sankyo INC. | $377.50 | 2019-2025 | Enhertu, Datroway, Injectafer |
| Abbvie INC. | $369.47 | 2019-2025 | |
| Pfizer INC. | $356.05 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $254.68 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Eisai INC. | $217.46 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $191.27 | 2019-2025 | Ultomiris |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.